Home
Investments
Philosophy
Press
About
Contact
Successful Exits
Archives
Archives
Prellis Biologics Appoints New CEO, Raises $35 Million in Series C Funding to Leverage Human Immune System Biology to De-Risk and Accelerate Therapeutics Drug Discovery and Development
Posted on Aug 10, 2022
Recent Posts
Allermi Secures $3.5M in Seed Funding to Meet Growing Demand for Customized Approach to Allergy Symptoms
Signifyd and commercetools partner in first-ever dynamic exemption management offering
Allermi is Pleased to Announce its Expansion into States Across the United States
TransAstra Awarded Two Contracts to Develop Critical Emerging Technologies in Orbital Debris Removal and Space Domain Awareness
SCOTT hits the trails with new Ultra Carbon RC run shoe
Recent Posts
Allermi Secures $3.5M in Seed Funding to Meet Growing Demand for Customized Approach to Allergy Symptoms
Signifyd and commercetools partner in first-ever dynamic exemption management offering
Allermi is Pleased to Announce its Expansion into States Across the United States
TransAstra Awarded Two Contracts to Develop Critical Emerging Technologies in Orbital Debris Removal and Space Domain Awareness
SCOTT hits the trails with new Ultra Carbon RC run shoe